These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 99230)

  • 1. Macrophage involvement in the antitumor activity of Brucella abortus ether extract against experimental lung carcinoma metastases.
    Schultz RM; Pavlidis NA; Chirigos MA
    Cancer Res; 1978 Oct; 38(10):3427-31. PubMed ID: 99230
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel.
    Schultz RM; Chirigos MA; Pavlidis NA; Youngner JS
    Cancer Treat Rep; 1978 Nov; 62(11):1937-41. PubMed ID: 103619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymhocyte stimulatory effect of an ether-extracted preparation of Brucella abortus.
    Stylos WA; Chirigos MA; Lengel CR
    Cancer Treat Rep; 1978 Nov; 62(11):1949-54. PubMed ID: 310345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to tumor graft in mice treated with inactivated Brucella abortus cultured in smooth or rough phase.
    Martin A; Toujas L; Le Garrec Y; Dazord L; Amice J
    J Natl Cancer Inst; 1979 Jan; 62(1):123-7. PubMed ID: 102858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of cell walls from Brucella abortus.
    Collet B; Martin A; Le Garrec Y; Dubray G; Toujas L
    J Natl Cancer Inst; 1983 Sep; 71(3):529-34. PubMed ID: 6411957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between macrophage migration inhibition and immunity to Brucella abortus in guinea-pigs.
    Cameron CM; Van Rensburg JJ; Engelbrecht MM
    Onderstepoort J Vet Res; 1976 Dec; 43(4):175-84. PubMed ID: 828715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortus.
    Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
    Cancer Treat Rep; 1978 Nov; 62(11):1931-5. PubMed ID: 282007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased resistance to tumor graft in mice infected by vaccinal strains of Brucella abortus.
    Dazord L; le Garrec Y; Bonnier M; Toujas L
    Recent Results Cancer Res; 1980; 75():92-9. PubMed ID: 6785847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in five strains of mice.
    Phillips M; Pugh GW; Deyoe BL
    Am J Vet Res; 1989 Mar; 50(3):318-22. PubMed ID: 2494912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Brucella abortus on growth of ovarian granulosa cell carcinoma].
    Litvinkova NP; Trubcheninova LP; Baryshnikov AIu
    Biull Eksp Biol Med; 1980 Nov; 90(11):600-2. PubMed ID: 6778536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the activity of a Brucella abortus preparation, Bru-Pel.
    Youngner JS; Feingold DS; Keleti G
    Cancer Treat Rep; 1978 Nov; 62(11):1915-8. PubMed ID: 728911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage function in mammary glands of Brucella abortus-infected cows and cows that resisted infection after inoculation of Brucella abortus.
    Harmon BG; Adams LG; Templeton JW; Smith R
    Am J Vet Res; 1989 Apr; 50(4):459-65. PubMed ID: 2496628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron augments macrophage-mediated killing of Brucella abortus alone and in conjunction with interferon-gamma.
    Jiang X; Baldwin CL
    Cell Immunol; 1993 May; 148(2):397-407. PubMed ID: 8495498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.
    Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ
    Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brucella abortus lipopolysaccharide is mitogenic for spleen cells of endotoxin-resistant C3H/HeJ mice.
    Moreno E; Berman DT
    J Immunol; 1979 Dec; 123(6):2915-9. PubMed ID: 115923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostimulation by Brucella abortus. Role of surface antigenicity of the bacteria.
    Toujas L; Le Garrec Y; Dazord L; Martin A
    Eur J Cancer (1965); 1977; 13(4-5):493-5. PubMed ID: 406141
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of a residual Brucella abortus 19 vaccine infection in mice by a virulent challenge or by injection of brucellin or of Brucella lipopolysaccharide.
    Plommet M; Plommet AM
    Ann Rech Vet; 1988; 19(4):245-51. PubMed ID: 3148291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of Brucella abortus in phagocytes. The immunophagocytic test of the activity of anti-brucellar vaccines and their immunostimulants].
    Joubert LM; Valette LR
    Bull Acad Vet Fr; 1967 Mar; 40(3):111-24. PubMed ID: 4985093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.